Clinical Trial Update: Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose [Phase 2]

View source ↗

Summary

Phase 2 trial of IXT-m200 for toxicity from methamphetamine overdose was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Intoxication

Drugs mentioned

• IXT-m200

Snippet

Sponsor: InterveXion Therapeutics, LLC | Conditions: Methamphetamine Intoxication (Disorder) | Phase 2 | Status: TERMINATED | Results posted: 2023-11-18